Communication Bridge 3 Study
ConditionPrimary Progressive Aphasia
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Chicago
About this trial
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
Eligibility criteria
Qualifiers
Meets diagnostic criteria for PPA based on neurologist and supporting medical assessments (extracted from medical records)
English as primary language used in daily communication activities (by self-report)
Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
Adequate vision (aided or unaided) for reading a newspaper, or other functional materials (by self-report)
Disqualifiers
A dementia diagnosis other than Primary Progressive Aphasia
Participation is co-enrolled in an outside speech language therapy program during the study course.
Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia)
Trial design
Treatments tested in this trial
- Communication Bridge™
- Evidence-Based Impairment Focused
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Chicago
Lead sponsor
Western University, Canada
Collaborator
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov